ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1686

The Prevalence of Depressive Symptoms and Persistent Depression among Older Adults with Systemic Lupus Erythematosus (SLE)

Patti Katz1, Sofia Pedro2 and Kaleb Michaud3, 1UCSF, San Rafael, CA, 2Forward, The National Databank for Rheumatic Diseases, Wichita, KS, 3University of Nebraska Medical Center, Omaha, NE

Meeting: ACR Convergence 2025

Keywords: depression, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: Abstracts: ARP I: Multidimensional Influences on Health in SLE (1686–1691)

Session Type: Abstract Session

Session Time: 3:00PM-3:15PM

Background/Purpose: Depression is reported to be common in SLE, but little is known about depressive symptoms among older adults with SLE.  While the burden of comorbid conditions and the cumulative effects of SLE may be heightened in this group,1 odds of depression are higher in younger age groups in the general population.2  Screening for depression appears to be uncommon in rheumatology settings.  We compared depressive symptom levels and the self-reported awareness of depression among older adults with SLE to those with RA and OA.

Methods: Data were from FORWARD, The National Databank for Rheumatic Diseases, a longitudinal observational cohort.  Data are collected semiannually.  Individuals with diagnosed SLE, rheumatoid arthritis (RA), and osteoarthritis (OA) were included in analyses; those with concurrent fibromyalgia were excluded.  Depressive symptoms were assessed with the Patient Heath Questionnaire (PHQ)-8 over 4 survey periods.  PHQ-8 scores were classified as ≥mild (≥5) or ≥moderate (≥10) levels of depressive symptoms. Persistent depression was defined as mild/moderate symptoms at ≥2 time points.  Generalized estimating equation (GEE) regression analyses (unadjusted and adjusted for age, sex, education, disease duration, physical function, and pain) compared scores among the 3 groups.  The proportion of individuals with notable levels of depressive symptoms who did not self-report with depression was examined.

Results: Data from 3770 participants (12,896 observations) were included (SLE n=179, obs=663; RA n=2088, obs=7792; OA n=1503, obs=4441).  Mean age was 69±8 years (Table 1).  Across years, with only one exception, older adults with SLE had higher PHQ-8 scores and higher frequencies of scores ≥5, and ≥10. Any occurrence of PHQ-8 scores ≥10 was seen in 21.0%, 18.2%, and 11.0% of those with SLE, RA, and OA, respectively.  Persistent PHQ-8 scores ≥10 were found in 11.4%, 11.6%, and 8.2% of those with SLE, RA, and OA.  GEE analyses (unadjusted and adjusted) showed significantly higher PHQ-8 scores and significantly higher prevalence of mild depressive symptoms in SLE compared to RA and OA (Table 2). Prevalence of moderate symptoms were significantly higher in SLE compared to OA in unadjusted analyses, but differences were attenuated after adjustment. In each year, at least 2/3 of those with ≥mild and about half of those with ≥moderate depressive symptoms did not self-report having depression (Table 3).

Conclusion: Older adults with SLE appear to carry a greater burden of depressive symptoms than individuals of similar age with RA or OA, and large portions of individuals seem to be unaware of having depressive symptoms.  Given this lack of awareness, the reported low levels of screening, and the significant impact of depression on health and well-being, results support greater attention to mental health in clinical encounters, particularly among older adults with SLE.
 
1 Leiber S et al.  J Rheumatol 2025; 52:145-150.
2 Hasin D et al. JAMA Psychiatry 2018; 75:336-346

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: P. Katz: None; S. Pedro: None; K. Michaud: None.

To cite this abstract in AMA style:

Katz P, Pedro S, Michaud K. The Prevalence of Depressive Symptoms and Persistent Depression among Older Adults with Systemic Lupus Erythematosus (SLE) [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/the-prevalence-of-depressive-symptoms-and-persistent-depression-among-older-adults-with-systemic-lupus-erythematosus-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-prevalence-of-depressive-symptoms-and-persistent-depression-among-older-adults-with-systemic-lupus-erythematosus-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology